Clinical trial Recruiting at 1 site Interventional Ages 11 to 18

Characterization of Visual Perception Impairments in Idiopathic Scoliosis

Official title: Characterization of Visual Perception Alterations in Patients With Idiopathic Scoliosis: Towards a Theory of Perceptual Imbalance

Run by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française · NCT07356999 · Data updated 2026-11-12

This study tests whether teens with idiopathic scoliosis have visual perception issues that relate to balance, compared with their peers.

Quick facts

Study typeInterventional
Ages11 Years to 18 Years
SexAll
Enrollment70 (estimated)
SponsorCentre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
Academic / other
Locations1 site (Lyon)
StatusRecruiting
StartedApril 21, 2026
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedMay 26, 2026
Trial IDNCT07356999 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 11–18 year-old patients with progressive idiopathic scoliosis scheduled for brace or corrective surgery and who can complete a multimodal balance assessment.

Probably not a fit

Patients without visual perception or balance impairments may see no direct benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study investigates whether teenagers with progressive idiopathic scoliosis have differences in visual perception that may affect balance. It uses motion analysis to examine multimodal balance inputs, including vision, proprioception, and the vestibular system, in affected and control groups aged 11 to 18. Participants planned for either brace or surgical correction will undergo a pre-therapy multimodal assessment. The aim is to understand if altered visual processing contributes to scoliosis progression and balance problems. The trial is conducted at a single center in Lyon, France, led by Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française.

Why it matters

Potential benefit: If successful, findings could clarify the role of vision in scoliosis and guide more holistic balance-focused assessments and interventions.

How similar studies have gone: Previous research has explored balance inputs in scoliosis, but this study is among the first to link visual perception specifically to idiopathic scoliosis in a multimodal framework.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Group Scoliosis:

* Girls or boys aged 11 to 18 inclusive.
* Patients with progressive idiopathic scoliosis
* Candidates for either orthopedic (brace) or surgical (arthrodesis correction) treatment for which a pre-therapeutic multimodal assessment is planned.

Control group:

\- Girls or boys aged 11 to 18 inclusive.

Exclusion Criteria:

The following individuals will not be included:

* Individuals with another musculoskeletal disorder.
* Individuals with a neurosensory disorder that may affect the balance of the trunk or lower limbs.
* Individuals with uncorrected visual perception disorders (visual check within 12 months prior to the examination).
* Lack of consent from the subject.
* Lack of consent from legal representatives.
* Failure to understand the instructions for performing the tests.

In addition, for the control group:

\- Suffering from scoliosis

Where it's running

  • Centre Médico chirurgical de Réadaptation des Massues
    Lyon, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.